Books on the topic 'Multidrug resistance'

T, Paulsen Ian, and Lewis Kim, eds. Microbial multidrug efflux. Wymondham: Horizon Scientific, 2002.

Boumendjel, Ahcne, Jean Boutonnat, and Jacques Robert, eds. ABC Transporters and Multidrug Resistance. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2009. http://dx.doi.org/10.1002/9780470495131.

Ahcène, Boumendjel, Boutonnat Jean, and Robert Jacques M. D, eds. ABC transporters and multidrug resistance. Hoboken, N.J: John Wiley & Sons, 2009.

A, Kellen John, ed. Reversal of multidrug resistance in cancer. Boca Raton, Fla: CRC Press, 1994.

Kellen, John A., ed. Alternative Mechanisms of Multidrug Resistance in Cancer. Boston, MA: Birkhäuser Boston, 1995. http://dx.doi.org/10.1007/978-1-4615-9852-7.

A, Kellen John, ed. Alternative mechanisms of multidrug resistance in cancer. Boston: Birkhäuser, 1995.

Parliamentary Office of Science and Technology. Diseases fighting back. London: Parliamentary Office of Science and Technology, 1994.

Lee, Peter Daniel. Analysis of multidrug resistance gene expression in osteosarcoma. Ottawa: National Library of Canada, 1994.

Ulincy, Loretta D. Multidrug resistance: January 1988 through September 1992 : 2250 citations. Bethesda, Md. (8600 Rockville Pike, Bethesda 20894): U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Library of Medicine, Reference Section, 1992.

Border, Peter. Diseases fighting back: The growing resistance of TB and other bacterial diseases to treatment. London: Parliamentary Office of Science and Technology, 1994.

Roninson, Igor B., ed. Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells. Boston, MA: Springer US, 1991. http://dx.doi.org/10.1007/978-1-4615-3794-6.

B, Roninson Igor, ed. Molecular and cellular biology of multidrug resistance in tumor cells. New York: Plenum Press, 1991.

Agoston, Meszaros, and Balogh Gusztav, eds. Multiple drug resistance. Hauppauge, NY: Nova Science Publishers, 2009.

Meszaros, Agoston. Multiple drug resistance. New York: Nova Science Publishers, 2010.

Matteo, Zignol, and WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance., eds. Anti-tuberculosis drug resistance in the world: Fourth global report : the World Health Organization/International Union Against Tuberculosis and Lung Disease (WHO/UNION) Global Project on Anti-Tuberculosis Drug Resistance Surveillance, 2002-2007. Geneva, Switzerland: World Health Organization, 2008.

Wright, Abigail. Anti-tuberculosis drug resistance in the world: Fourth global report : the World Health Organization/International Union Against Tuberculosis and Lung Disease (WHO/UNION) Global Project on Anti-Tuberculosis Drug Resistance Surveillance, 2002-2007. Geneva, Switzerland: World Health Organization, 2008.

Lee, Gigi. Influence of cytokines on multidrug resistance transporters in human hepatoma cell lines. Ottawa: National Library of Canada, 2001.

Ford, James Matthew. Identification and characterization of a novel class of pharmacologic agents for the reversal of multidrug resistance. [New Haven: s.n.], 1989.

Hopkins, Tanne Janice, ed. Timebomb: The global epidemic of multi-drug-resistant tuberculosis. New York: McGraw-Hill, 2002.

The global threat of drug-resistant TB: A call to action for World TB Day : briefing and hearing before the Subcommittee on Africa and Global Health of the Committee on Foreign Affairs, House of Representatives, One Hundred Tenth Congress, first session, March 21, 2007. Washington: U.S. G.P.O., 2007.

Jennings, Andrew Melvin. Reversal of multidrug resistance in bladder cancer cell lines with estramustine and its derivatives. Portsmouth: University of Portsmouth, 2005.

Multi-drug resistance in cancer. Totowa, N.J: Humana, 2010.

Muzzammil, Tassawwar. Application of radionuclide methods in determining the importance of P-glycoprotein function in multidrug resistance. Ottawa: National Library of Canada, 1998.

Falzon, Dennis. Guidelines for surveillance of drug resistance in tuberculosis. 4th ed. Geneva: World Health Organization, 2009.

Vinšová, Jarmila. Development of new MDR-tuberculosis drugs. Hauppauge, N.Y: Nova Science Publisher, 2010.

Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation, ed. Addressing the threat of drug-resistant tuberculosis: A realistic assessment of the challenge : workshop summary. Washington, D.C: National Academies Press, 2009.

Kelly, Evelyn B. Investigating tuberculosis and superbugs: Real facts for real lives. Berkeley Heights, NJ: Enslow Publishers, 2011.

Bard, Shannon Mala. Characterization of P-glycoprotein expression as a multixenobiotic resistance mechanism in fish. Cambridge, Mass: Massachusetts Institute of Technology, 2001.

Bard, Shannon Mala. Characterization of P-glycoprotein expression as a multixenobiotic resistance mechanism in fish. Cambridge, Mass: Massachusetts Institute of Technology, 2001.

author, Wilker Ian, and Ambrose Marylou author, eds. Tuberculosis and superbugs: Examining TB and bacterial infections. Berkeley Heights, NJ: Jasmine Health, 2014.

Albino, Christine D. RNA-protein interactions within the 3'untranslated region (3'UTR) of the human multidrug resistance type 1 (MDR1). Ottawa: National Library of Canada, 2000.

A, Moscow Jeffrey, and National Cancer Institute (U.S.). Office of Cancer Communications, eds. Heterogeneous expression in human tumors of anionic glutathione-S-transferase, a phase II enzyme associated with multidrug resistance. [Bethesda, Md.]: National Cancer Institute, Office of Cancer Communications, 1988.

Gannon, Brian R. Dominant inhibition of cyclic AMP - dependent protein kinase in MCF-7 breast cancer cells: Effects on multidrug resistance. Sudbury, Ont: Laurentian University, 1997.

Takashi, Tsuruo, Ogawa M, and Bristol-Myers Squibb Drug Resistence in Cancer Symposium (1990 : Tokyo, Japan), eds. Drug resistance as a biochemical target in cancer chemotherapy. San Diego: Academic Press, 1992.

Fighting superbugs: DOD's response to multidrug-resistant infections in military treatment facilities : hearing before the Subcommittee on Oversight and Investigations of the Committee on Armed Services, House of Representatives, One Hundred Eleventh Congress, second session, hearing held September 29, 2010. Washington: U.S. G.P.O., 2010.

File, Thomas. New insights in the treatment of severe infections in the multiple-drug resistant situation: Proceedings of a satellite symposium to the 11th International Congress on Infectious Diseases, Cancun, Mexico, March 5, 2004. Basel, Switzerland: Karger, 2004.

Bastian, Ivan, and Françoise Portaels, eds. Multidrug-resistant Tuberculosis. Dordrecht: Springer Netherlands, 2000. http://dx.doi.org/10.1007/978-94-011-4084-3.

Kim, Kŏn-hong. Yubangam ŭi taje yangmul naesŏng saengchʻe chipʻyo palgul mit kŭ yuyongsŏng kŏmjŭng =: Identification of biomarkers for multidrug resistance and validation of markers in breast cancer tissue. [Seoul]: Sikpʻum Ŭiyakpʻum Anjŏnchʻŏng, 2007.

H, Gillespie S., ed. Management of multiple drug-resistant infections. Totowa, N.J: Humana Press, 2004.

Multidrug Resistance-Associated Proteins. Nova Science Publishers, 2006.

Combination Therapy Against Multidrug Resistance. Elsevier, 2020. http://dx.doi.org/10.1016/c2019-0-01422-7.

Wani, Mohmmad Younus, and Aijaz Ahmad. Combination Therapy Against Multidrug Resistance. Elsevier Science & Technology, 2020.

U. Khan, Asad, and Raffaele Zarrilli, eds. Multidrug Resistance: A Global Concern. BENTHAM SCIENCE PUBLISHERS, 2012. http://dx.doi.org/10.2174/97816080529291120101.

Robert, Jacques, Ahcène Boumendjel, Jean Boutonnat, and Ahcène Boumendjel. ABC Transporters and Multidrug Resistance. Wiley & Sons, Incorporated, John, 2009.

Boumendjel, Ahcne, Ahc Boumendjel, Jacques Robert, and Jean Boutonnat. ABC Transporters and Multidrug Resistance. Wiley & Sons, Incorporated, John, 2009.

Wani, Mohmmad Younus, and Aijaz Ahmad. Combination Therapy Against Multidrug Resistance. Elsevier Science & Technology Books, 2020.

Kartner, Norbert *. P-glycoprotein and multidrug resistance. 1988.

Kellen, John A. Alternative Mechanisms of Multidrug Resistance in Cancer. Birkhauser, 2012.

Kellen, John A. Alternative Mechanisms of Multidrug Resistance in Cancer. Birkhauser Verlag, 2012.

(Editor), I. Bastian, and F. Portaels (Editor), eds. Multidrug-Resistant Tuberculosis (Resurgent and Emerging Infectious Diseases). Springer, 2000.